Seqonce
2 known investors
Find your way into Seqonce
Sign up to see every warm intro you have to Seqonce
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Seqonce team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bandit Biosystems develops research-use-only multiplex qPCR and RT-qPCR pathogen panels, matched amplification master mixes, and rapid NGS library prep for molecular laboratories, public health groups and assay developers. It also designs custom singleplex and multiplex assays tailored to a lab's targets, dye sets and instruments, with products manufactured in the USA.
Investors · 2
Embark Ventureslisted by Embark VenturesLos Angeles · $100K – $2M
How we know: Embark Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Wavemaker Three-Sixty Healthlisted by Wavemaker Three-Sixty HealthPasadena · $500K – $2M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Seqonce do?
- Bandit Biosystems develops research-use-only multiplex qPCR and RT-qPCR pathogen panels, matched amplification master mixes, and rapid NGS library prep for molecular laboratories, public health groups and assay developers. It also designs custom singleplex and multiplex assays tailored to a lab's targets, dye sets and instruments, with products manufactured in the USA.
- Who are Seqonce's investors?
- Seqonce's investors include Embark Ventures, Wavemaker Three-Sixty Health.

